Skip to main content

Advertisement

Log in

White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Analgesic overuse often happens to migraine patients, especially chronic migraineurs, and migraine has been demonstrated to be associated with white matter lesions (WMLs). The aim of this study was to investigate the relationship between medication overuse headache (MOH) and WMLs in chronic migraine (CM) patients. Subjects were enrolled and divided into three groups: healthy controls, CM without MOH (CMwoMOH), and CM with MOH (CM-MOH). Most of the CM patients used non-steroidal anti-inflammatory drugs (NSAIDs) as acute headache medications. All the participants underwent magnetic resonance imaging scans and images were obtained for WML evaluation with semiquantitative scales. One hundred and forty-one participants were included, 45 of them for controls, 38 for CMwoMOH, and 58 for CM-MOH. In women, CMwoMOH patients had a higher prevalence of high WML load compared with controls and CM-MOH patients. In men, however, all the study groups showed no differences in the prevalence of high WML load. CMwoMOH women had increased risks of high deep white matter lesion (DWML) load compared with controls, while they had no risks of high periventricular white matter lesion (PVWML) load. CM-MOH women had no risks of high DWML load, but they had reduced risks of high PVWML load. The association of CM-MOH with high WML load in women was not changed when compared with CMwoMOH. Age was independently associated with high WML load among women. These data suggest that MOH caused by NSAIDs is not a risk factor for WMLs. Rather, NSAID overuse probably protects MOH patients from WMLs through anti-inflammatory effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Adami A, Rossato G, Cerini R, Thijs VN, Pozzi-Mucelli R, Anzola GP, Del SM, Finocchi C, Meneghetti G, Zanferrari C (2008) Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 71:101–107

    Article  CAS  PubMed  Google Scholar 

  2. Chiapparini L, Ferraro S, Grazzi L, Bussone G (2010) Neuroimaging in chronic migraine. Neurol Sci 31(Suppl 1):S19–S22

    Article  PubMed  Google Scholar 

  3. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9–14

    Article  PubMed Central  PubMed  Google Scholar 

  4. Di W, Shi X, Zhu Y, Tao Y, Qi W, Luo N, Xiao Z, Yi C, Miao J, Zhang A, Zhang X, Fang Y (2013) Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients. Eur J Neurol 20:655–662

    Article  CAS  PubMed  Google Scholar 

  5. Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401

    Article  PubMed  Google Scholar 

  6. Ferraro S, Grazzi L, Mandelli ML, Aquino D, Di Fiore D, Usai S, Bruzzone MG, Di Salle F, Bussone G, Chiapparini L (2012) Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med 13:255–262

    Article  PubMed  Google Scholar 

  7. Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543–550

    Article  PubMed  Google Scholar 

  8. Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ (1990) The mini-mental state examination in the early diagnosis of Alzheimer’s disease. Arch Neurol 47:49–52

    Article  CAS  PubMed  Google Scholar 

  9. Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR (2005) CGRP and migraine: neurogenic inflammation revisited. J Headache Pain 6:61–70

    Article  PubMed Central  PubMed  Google Scholar 

  10. Gupta VK (2009) CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother 9:1595–1614

    Article  CAS  PubMed  Google Scholar 

  11. Kara B, Kiyat AA, Onat L, Ulusoy L, Mutlu A, Sirvanci M (2013) DTI findings during spontaneous migraine attacks. Clin Neuroradiol 23:31–36

    Article  CAS  PubMed  Google Scholar 

  12. Kruit MC, Thijs RD, Ferrari MD, Launer LJ, van Buchem MA, van Dijk JG (2013) Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. Neurology 80:1958–1965

    Article  PubMed Central  PubMed  Google Scholar 

  13. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434

    Article  CAS  PubMed  Google Scholar 

  14. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30:129–136

    PubMed Central  CAS  PubMed  Google Scholar 

  15. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, Bousser MG, Dufouil C, Tzourio C (2011) Headache, migraine, and structural brain lesions and function: population based epidemiology of vascular ageing-MRI study. BMJ 342:c7357

    Article  PubMed Central  PubMed  Google Scholar 

  16. Miller SP, Mayer EE, Clyman RI, Glidden DV, Hamrick SE, Barkovich AJ (2006) Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks’ gestation at birth. Pediatrics 117:1626–1631

    Article  PubMed  Google Scholar 

  17. Morales OY, Jinka M, Ziai WC (2010) Severe leukoencephalopathy following acute oxycodone intoxication. Neurocrit Care 13:93–97

    Article  Google Scholar 

  18. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746

    Article  CAS  PubMed  Google Scholar 

  19. Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC (2012) Structural brain changes in migraine. JAMA 308:1889–1897

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Park HK, Lee SY, Kim SE, Yun CH, Kim SH (2011) Small deep white matter lesions are associated with right-to-left shunts in migraineurs. J Neurol 258:427–433

    Article  PubMed  Google Scholar 

  21. Rozen TD (2010) Images from headache: white matter lesions of migraine are not static. Headache 50:305–306

    Article  PubMed  Google Scholar 

  22. Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM (2010) Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. AJNR Am J Neuroradiol 31:565–566

    Article  CAS  PubMed  Google Scholar 

  23. Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, van Buchem MA (2008) Attack frequency and disease duration as indicators for brain damage in migraine. Headache 48:1044–1055

    Article  PubMed  Google Scholar 

  24. Seet RC, Rathakrishnan R, Chan BP, Lim EC (2005) Diffuse cystic leucoencephalopathy after buprenorphine injection. J Neurol Neurosurg Psychiatry 76:890–891

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ (2005) The international classification of headache disorders, 2nd edn. (ICHD-II): revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25:460–465

  26. Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61:1366–1368

    Article  PubMed  Google Scholar 

  27. Trauninger A, Leel-Ossy E, Kamson DO, Poto L, Aradi M, Kover F, Imre M, Komaromy H, Erdelyi-Botor S, Patzko A, Pfund Z (2011) Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J Headache Pain 12:97–103

    Article  PubMed Central  PubMed  Google Scholar 

  28. Turkoglu R, Tuzun E, Icoz S, Birisik O, Erdag E, Kurtuncu M, Akman-Demir G (2011) Antineuronal antibodies in migraine patients with white matter lesions. Int J Neurosci 121:33–36

    Article  PubMed  Google Scholar 

  29. Wakita H, Tomimoto H, Akiguchi I, Lin JX, Miyamoto K, Oka N (1999) A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. NeuroReport 10:1461–1465

    Article  CAS  PubMed  Google Scholar 

  30. Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211:23–30

    Article  CAS  PubMed  Google Scholar 

  31. Yoon GJ, Kim JT, Chang J, Kim DE, Cho BH, Lee JH, Jung HJ, Lee SH, Choi SM, Park MS, Cho KH (2012) Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol 19:1086–1092

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The WML rating was performed by Zhifeng Chen and Bing Zhang from Department of Radiology, the First Affiliated Hospital, Sun Yat-sen University. The authors are grateful to Prof. Mark W. Massing from the Carolinas Center for Medical Excellence for his assistance in writing this manuscript. This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81171101), National Key Discipline and National Key Clinical Department.

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Aiwu Zhang or Yannan Fang.

Additional information

Z. Zheng and Z. Xiao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, Z., Xiao, Z., Shi, X. et al. White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study. J Neurol 261, 784–790 (2014). https://doi.org/10.1007/s00415-014-7267-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-014-7267-1

Keywords

Navigation